Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 133

Sort by

Sort Order Select

Journal Articles

Mechanistic Insights into the Inhibition of T Regulatory Cells By Dasatinib May Predict Immunostimulatory Effects in CML Patients

Patrick Harrington, MRCP, FRCPath, Richard Dillon, MA, PhD MRCP, FRCPath, Philippe Rousselot, MD PhD, Deepti Radia, Yvonne Francis, Claire N Harrison, Professor, Shahram Kordasti, MD PhD, Hugues De Lavallade

Blood (2019) 134 (Supplement_1): 1635.

https://doi.org/10.1182/blood-2019-129135

Published: 2019

Journal Articles

T Cell Activation By OKT3 Is a Function of the Percent Monocytes in PBMC of Healthy Donors and MDS Patients

Alison Tarke, Valentina Ferrari, BA, Hannah Fields, Luca Ferrari, Franco Ferrari, PhD, Tiffany N Tanaka, MD, Rafael Bejar, MD PhD, Antonella Vitiello, Dr. Pharm., Thomas A Lane, MD

Blood (2019) 134 (Supplement_1): 4870.

https://doi.org/10.1182/blood-2019-131474

Published: 2019

Journal Articles

A Protein-Based Method to Develop Allogeneic Chimeric Antigen Receptor T-Cells

Paul Maciocia, BSc, MBChB, MRCP, Patrycja Wawrzyniecka, Leo Kassimatis, Martin Pule, MD

Blood (2018) 132 (Supplement 1): 700.

https://doi.org/10.1182/blood-2018-99-112544

Published: 2018

Journal Articles

Exceptionally Potent Cytotherapy Using T Cells Armed with Novel Tetravalent Recombinant Bispecific Antibodies Specific for GD2 and HER2

Jeong A Park, MD PhD, Hong Xu, PhD, Brian Santich, PhD, Nai-Kong V. Cheung, MD PhD

Blood (2018) 132 (Supplement 1): 4536.

https://doi.org/10.1182/blood-2018-99-120210

Published: 2018

Journal Articles

B-Cell Receptor Antigens As the Targeting Moiety for Bispecific Constructs - a Novel Treatment Approach for B-Cell Lymphomas

Moritz Bewarder, MD, Lorenz Thurner, MD, Klaus Dieter Preuss, PhD, Evi Regitz, Natalie Fadle, Michael Pfreundschuh, MD

Blood (2017) 130 (Supplement 1): 111.

https://doi.org/10.1182/blood.V130.Suppl_1.111.111

Published: 2017

Journal Articles

How to Identify Patients for Treg DLI - Treg Subsets in Gvhd As Biomarker for Successful Treg DLI

Pascal Wölfinger, Lukas Schäfer, Katharina Epp, Matthias Theobald, MD PhD, Tobias Bopp, Eva-Maria Wagner, MD

Blood (2017) 130 (Supplement 1): 1989.

https://doi.org/10.1182/blood.V130.Suppl_1.1989.1989

Published: 2017

Journal Articles

TCR-Identical CD8+ T-Cells Can Have Distinct Killing Efficacy Determined By Events Beyond the T-Cell Receptor

Julie M Glanville, Anne-Marie Moody, Yanchun Peng, Stephan Taylor, Kristin Ladell, Geraldine Gillespie, Godelieve de Bree, Dilair Baban, Guillaume Stewart-Jones, Claire Cullen, Adam J Mead, MD PhD, Emmanuela Repapi, Sarah Rowland-Jones, Alison Simmons, David A Price, Tao Dong, Andrew McMichael

Blood (2017) 130 (Supplement 1): 692.

https://doi.org/10.1182/blood.V130.Suppl_1.692.692

Published: 2017

Journal Articles

A Novel Combination of Anti-CD3 x Anti-CD123 Monoclonal Antibodies to Redirect Activated T Cells to Target Acute Myelogenous Leukemia

Ewa Kubicka, MS, Lawrence G. Lum, MD, Archana Thakur, PhD

Blood (2017) 130 (Supplement 1): 5066.

https://doi.org/10.1182/blood.V130.Suppl_1.5066.5066

Published: 2017

Journal Articles

Safety Data from a First-in-Human Phase 1 Trial of NKG2D Chimeric Antigen Receptor-T Cells in AML/MDS and Multiple Myeloma

Blood (2016) 128 (22): 4052.

https://doi.org/10.1182/blood.V128.22.4052.4052

Published: 2016

Journal Articles

CD3/Bars: A Novel Bispecific Format for the Treatment of B-Cell Lymphomas

Moritz Bewarder, MD, Klaus-Dieter Preuss, PhD, Natalie Fadle, Evi Regitz, Lorenz Thurner, MD, Michael Pfreundschuh, MD, PhD

Blood (2016) 128 (22): 3516.

https://doi.org/10.1182/blood.V128.22.3516.3516

Published: 2016

Journal Articles

Second Hematopoietic SCT for Thalassemia Major: Improved Clinical Outcomes with a Treosulfan Based Conditioning Regimen

Vikram Mathews, MD DM, Anu Korula, MD DM, Nisham PN, MD DM, Anup Joseph Devasia, MD DM, Fouzia NA, Dip NB, DM,, Kavitha M Lakshmi, MSc, Aby Abraham, MD DM, Biju George, MD DM, Alok Srivastava

Blood (2016) 128 (22): 2201.

https://doi.org/10.1182/blood.V128.22.2201.2201

Published: 2016

Journal Articles

A Novel Phase-Change Hydrogel Substrate for T Cell Activation Promotes Increased Expansion of CD8+ Cells Expressing Central Memory and Naive Phenotype Markers

Nithya J Jesuraj, PhD, Julie M Cole, BA, BS, Felipe Bedoya, PhD, Steven B Wells, BS, Guokui Qin, PhD, Sean Kevlahan, PhD, Marcela V. Maus, MD PhD, Andrew J Ball, PhD

Blood (2016) 128 (22): 3368.

https://doi.org/10.1182/blood.V128.22.3368.3368

Published: 2016

Journal Articles

Transfer of Immunity Using Vaccinate and Boost Strategy with Bispecific Antibody Armed T Cells (BATs) in Metastatic Breast Cancer Patients

Archana Thakur, PhD, Joseph P. Uberti, MD, PhD, Voravit Ratanatharathorn, MD, Lawrence G. Lum, MD DSC

Blood (2016) 128 (22): 3459.

https://doi.org/10.1182/blood.V128.22.3459.3459

Published: 2016

Journal Articles

Reduction in CMV and Adenovirus Viremia after Haploidentical Donor Transplantation Utilizing CD45RA Depletion and NK Cell Infusion

Brandon M. Triplett, MD, Bradley Muller, Guolian Kang, PhD, Shane J Cross, PharmD, Joseph Moen, Mari H Dallas, MD, Christine Hartford, MD, William E. Janssen, PhD, Ping Law, PhD, Ewelina K. Mamcarz, MD, David R Shook, MD, Ashok Srinivasan, MD, Randall T Hayden, MD, Wing Leung, MD PhD

Blood (2015) 126 (23): 624.

https://doi.org/10.1182/blood.V126.23.624.624

Published: 2015

Journal Articles

Improved Anti-Leukemia Activities of Adoptively Transferred T Cells Expressing Bites

Xiaojun Liu, Master, David M. Barrett, MD PhD, Shuguang Jiang, PhD, Chongyun Fang, PhD, Stephan A. Grupp, MD PhD, Carl H. June, MD, Yangbing Zhao, PhD MD

Blood (2015) 126 (23): 4431.

https://doi.org/10.1182/blood.V126.23.4431.4431

Published: 2015

Journal Articles

Mitochondrial Biomass As a Measure of Fitness for T Cells Expressing Chimeric Antigen Receptors

Bipulendu Jena, PhD, David Rushworth, MD PhD, George T McNamara, PhD, Laurence JN Cooper, MD PhD

Blood (2015) 126 (23): 3242.

https://doi.org/10.1182/blood.V126.23.3242.3242

Published: 2015

Journal Articles

A Multicenter Phase II Study of Sequential Administration of Unmanipulated DLI and Donor Derived Cytokine Induced Killer (CIK) Cells in HSCT Patients, Relapsed of Disease

Martino Introna, MD, Elisa Gotti, BA, Michela Bonzi, BA, Josee Golay, PhDBA, Alessandra Algarotti, MD, Caterina Micò, MD, Anna Grassi, MD, Cristina Boschini, Maria Luisa Ferrari, BSc, Irene Cavattoni, MD, Ettore Biagi, MD, Adriana Balduzzi, Sr., MD, Attilio Rovelli, MD, Paolo Perseghin, MD, Giuseppe Gaipa, PhD, Andrea Biondi, Alessandro Rambaldi, MD

Blood (2015) 126 (23): 3160.

https://doi.org/10.1182/blood.V126.23.3160.3160

Published: 2015

Journal Articles

Improved Immune Recovery after Transplantation of TCRαβ/CD19 Depleted Allografts from Haploidentical Donors in Pediatric Patients

Peter Lang, MD, Tobias Feuchtinger, MD, Heiko-Manuel Teltschik, MD, Wolfgang Schwinger, MD, Patrick Schlegel, MD, Michael Schumm, DVM, Anne-Marie Lang, Barbara Lang, MD, Carl Philipp Schwarze, MD, Martin Ebinger, MD, Christian E. Urban, MD, Rupert Handgretinger

Blood (2014) 124 (21): 852.

https://doi.org/10.1182/blood.V124.21.852.852

Published: 2014

Journal Articles

Novel TCR-like Bi-Specific T Cell Engaging Antibody Targeting the PR1/HLA-A2 Myeloid Leukemia Antigen

Jin Im, MD PhD, Amanda Cernosek, Anna Sergeeva, PhD, Jeffrey J. Molldrem, MD, Lu Sijie, PhD

Blood (2014) 124 (21): 2314.

https://doi.org/10.1182/blood.V124.21.2314.2314

Published: 2014

Journal Articles

Prior Granulocyte Colony-Stimulating Factor Treatment Enhances the Immediate and Transient Output of Primitive Hematopoietic Cells in the Blood of Normal Adult Human Donors Treated with Plerixafor

Paul H. Miller, Naoto Nakamichi, MDPhD, Gabrielle Rabu, Kirk R. Schultz, MD, David M. Jones, MD, Stephen Couban, MD FRCPC, Connie J. Eaves, PhD

Blood (2014) 124 (21): 5787.

https://doi.org/10.1182/blood.V124.21.5787.5787

Published: 2014

NARROW

Mechanistic Insights into the Inhibition of T Regulatory Cells By Dasatinib May Predict Immunostimulatory Effects in CML Patients

T Cell Activation By OKT3 Is a Function of the Percent Monocytes in PBMC of Healthy Donors and MDS Patients

A Protein-Based Method to Develop Allogeneic Chimeric Antigen Receptor T-Cells

Exceptionally Potent Cytotherapy Using T Cells Armed with Novel Tetravalent Recombinant Bispecific Antibodies Specific for GD2 and HER2

B-Cell Receptor Antigens As the Targeting Moiety for Bispecific Constructs - a Novel Treatment Approach for B-Cell Lymphomas

How to Identify Patients for Treg DLI - Treg Subsets in Gvhd As Biomarker for Successful Treg DLI

TCR-Identical CD8+ T-Cells Can Have Distinct Killing Efficacy Determined By Events Beyond the T-Cell Receptor

A Novel Combination of Anti-CD3 x Anti-CD123 Monoclonal Antibodies to Redirect Activated T Cells to Target Acute Myelogenous Leukemia

Safety Data from a First-in-Human Phase 1 Trial of NKG2D Chimeric Antigen Receptor-T Cells in AML/MDS and Multiple Myeloma

CD3/Bars: A Novel Bispecific Format for the Treatment of B-Cell Lymphomas

Second Hematopoietic SCT for Thalassemia Major: Improved Clinical Outcomes with a Treosulfan Based Conditioning Regimen

A Novel Phase-Change Hydrogel Substrate for T Cell Activation Promotes Increased Expansion of CD8+ Cells Expressing Central Memory and Naive Phenotype Markers

Transfer of Immunity Using Vaccinate and Boost Strategy with Bispecific Antibody Armed T Cells (BATs) in Metastatic Breast Cancer Patients

Reduction in CMV and Adenovirus Viremia after Haploidentical Donor Transplantation Utilizing CD45RA Depletion and NK Cell Infusion

Improved Anti-Leukemia Activities of Adoptively Transferred T Cells Expressing Bites

Mitochondrial Biomass As a Measure of Fitness for T Cells Expressing Chimeric Antigen Receptors

A Multicenter Phase II Study of Sequential Administration of Unmanipulated DLI and Donor Derived Cytokine Induced Killer (CIK) Cells in HSCT Patients, Relapsed of Disease

Improved Immune Recovery after Transplantation of TCRαβ/CD19 Depleted Allografts from Haploidentical Donors in Pediatric Patients

Novel TCR-like Bi-Specific T Cell Engaging Antibody Targeting the PR1/HLA-A2 Myeloid Leukemia Antigen

Prior Granulocyte Colony-Stimulating Factor Treatment Enhances the Immediate and Transient Output of Primitive Hematopoietic Cells in the Blood of Normal Adult Human Donors Treated with Plerixafor

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only